Increased interleukin (IL)-20 and IL-24 target osteoblasts and synovial monocytes in spondyloarthritis

T. W. Kragstrup*, M. N. Andersen, B. Schiøttz-Christensen, A. G. Jurik, M. Hvid, B. Deleuran

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


The pathogenesis of spondyloarthritis (SpA) involves activation of the innate immune system, inflammation and new bone formation. The two cytokines interleukin (IL)-20 and IL-24 have been shown to link innate immune activation and tissue homeostasis. We hypothesized that these two cytokines are secreted as part of activation of the innate immune system and affect bone homeostasis in SpA. IL-20 and IL-24 were measured in plasma from axial SpA patients (n = 83). Peripheral SpA patients (n = 16) were included for in-vitro cell culture studies. The plasma IL-20 and IL-24 levels were increased in SpA patients compared with healthy controls (HCs) by 57 and 83%, respectively (both P < 0·0001). The Toll-like receptor 4-induced secretion of the two cytokines was greater in SpA peripheral blood mononuclear cells (PBMCs) compared with HC PBMCs. IL-20 and IL-24 increased the production of monocyte chemoattractant protein-1 by activated SpA synovial fluid monocytes, decreased the production of Dickkopf-1 by SpA fibroblast-like synovial cells and induced mineralization in human osteoblasts. Taken together, our findings indicate disease-aggravating functions of IL-20 and IL-24 in SpA.

TidsskriftClinical and Experimental Immunology
Udgave nummer3
Sider (fra-til)342-351
StatusUdgivet - 2017

Fingeraftryk Dyk ned i forskningsemnerne om 'Increased interleukin (IL)-20 and IL-24 target osteoblasts and synovial monocytes in spondyloarthritis'. Sammen danner de et unikt fingeraftryk.